Aiken, L. S., and West, S. G. (1991). Multiple Regression: Testing and Interpreting Interactions, Sage, London.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC.
Anda, R. F., Williamson, D., and Jones, D. (1993). Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4: 285–294.
Appels, A., Bar, F. W., Bar, J., Bruggeman, C., and de Baets, M. (2000). Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med 62: 601–605.
Barefoot, J. C., Beckham, J. C., Haney, T. L., Siegler, I. C., and Lipkus, I. M. (1993). Age-differences in hostility among middle-aged and older adults. Psychol. Aging 8: 3–9.
Barefoot, J. C., Dahlstrom, W. G., and Williams, R. B. (1983). Hostility, CHD incidence, and total mortality. Psychosom. Med 45: 59–63.
Barefoot, J. C., Dodge, K. A., Peterson, B. L., Dahlstrom, W. G., and Williams, R. B. (1989). The Cook–Medley Hostility Scale: Item content and ability to predict survival. Psychosom. Med. 51: 46–57.
Barefoot, J. C., and Schroll, M. (1996). Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93: 1976–1980.
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A., Ginnetti, F., Dinarello, C. A., and Maseri, A. (1999). Increasing levels of interleukin-1ra and IL-6 during the first two days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99: 2079–2084.
Brindley, D. N., McCann, B. S., Niaura, R., Stoney, C. M., and Suarez, E. C. (1993). Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism 42: 3–15.
Carney, R. M., Freedland, K. E., Miller, G. E., and Jaffe, A. S. (2002). Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J. Psychosom. Res. 53: 897–902.
Carney, R. M., Rich, M. W., Freedland, K. E., te Velde, A. J., Saini, J., Simeone, C., and Clark, K. (1988). Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 50: 627–633.
Dembroski, T. M., MacDougall, J. M., Costa, P. T., and Grandits, G. A. (1989). Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial. Psychosom. Med. 51: 514–522.
Dentino, A. N., Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T., Blazer, D. G., and Cohen, H. J. (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Ger. Soc. 47: 6–11.
Everson, S. A., Goldberg, D. E., Kaplan, G. A., Cohen, R. D., Pukkala, E., Tuomilehto, J., and Salonen, J. T. (1996). Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58: 113–121.
Ford, D. E., Mead, L. A., Chang, P. P., Cooper-Patrick, L., Wang, N. Y., and Klag, M. J. (1998). Depression is a risk factor for coronary artery disease in men: The precursors study. Arch. Intern. Med. 158: 1422–1426.
Frasure-Smith, N., Lesperance, F., and Talajic, M. (1993). Depression following myocardial infarction. Impact on 6–month survival. JAMA 270: 1819–1825.
Frasure-Smith, N., Lesperance, F., and Talajic, M. (1995). Depression and 18–month prognosis after myocardial infarction. Circulation 91: 999–1005.
Freedland, K. E., Skala, J. A., Carney, R. M., Raczynski, J. M., Taylor, C. B., Mendes de Leon, C. F., Ironson, G., Youngblood, M. E., Krishnan, K. R., and Veith, R. C. (2002). The Depression Interview and Structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosom. Med. 64: 897–905.
Glassman, A. H., and Shapiro, P. A. (1998). Depression and the course of coronary artery disease. Am. J. Psychiatry 155: 4–11.
Kop, W. J., and Cohen, N. (2001). Psychological risk factors and immune system involvement in cardiovascular disease. In Ader, R., Felten, D., and Cohen, N. (Eds.), Psychoneuroimmunology, Academic Press, New York, pp. 525–544.
Kop, W. J., Gottdiener, J. S., Tangen, C. M., Fried, L. P., McBurnie, M. A., Walston, J., Newman, A. B., Hirsch, C., and Tracy, R. P. (2002). Inflammatory and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol 89: 419–424.
Libby, P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365–372.
Lutgendorf, S. K., Garand, L., Buckwalter, K. C., Reimer, T. T., Hong, S. Y., and Lubaroff, D. M. (1999). Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J. Gerontol. 54: M434–M439.
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., and Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9: 853–858.
Maier, S. F., and Watkins, L. R. (1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev 105: 83–107.
Matthews, K. A. (1988). CHD and Type A behaviors: Update on and alternative to the Booth–Kewley and Friedman quantitative review. Psychol. Bull. 104: 373–380.
Matthews, K. A., Glass, D. C., Rosenman, R. H., and Bortner, R. W. (1977). Competitive drive, pattern A, and coronary heart disease: A further analysis of some data from the Western Collaborative Group Study. J. Chron. Dis. 30: 489–498.
Mendes de Leon, C. F., Kop, W. J., de Swart, H. B., Bar, F., and Appels, A. (1996). Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 77: 252–255.
Miller, G. E., Dopp, J. M., Myers, H. F., Felten, S. Y., and Fahey, J. L. (1999). Psychosocial predictors of natural killer mobilization during marital conflict. Health Psychol. 18: 262–271.
Miller, G. E., Stetler, C. A., Carney, R. M., Freedland, K. E., and Banks, W. A. (2002). Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90: 1279–1283.
Miller, T. Q., Smith, T. W., Turner, C. W., Guijarro, M. L., and Hallet, A. J. (1996). A meta-analytic review of research on hostility and physical health. Psychol. Bull. 119: 322–348.
Morgan, R. E., Palinkas, L. A., Barrett-Connor, E. L., and Wingard, D. L. (1993). Plasma cholesterol and depressive symptoms in older men. Lancet 341: 75–79.
Musselman, D. L., Evans, D. L., and Nemeroff, C. B. (1998). The relationship of depression to cardiovascular disease. Arch. Gen. Psychiatry 55: 580–592.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., and Miller, A. H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344: 961–966.
Pratt, L. A., Ford, D. E., Crum, R. M., Armenian, H. K., Gallo, J. J., and Eaton, W. W. (1996). Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up. Circulation 94: 3123–3129.
Raynor, D. A., Pogue-Geile, M. F., Kamarck, T. W., McCaffrey, J. M., and Manuck, S. B. (2002). Covariation of psychosocial characteristics associated with cardiovascular disease: Genetic and environmental influences. Psychosom. Med. 64: 191–203.
Ridker, P. M., Hennekens, C. H., Buring, J. E., and Rifai, N. (2000a). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342: 836–843.
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., and Braunwald, E. (2000b). Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101: 2149–2153.
Ridker, P. M., Rifai, N., Stampfer, M. J., and Hennekens, C. H. (2000c). Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767–1772.
Robins, L. N., Helzer, J. E., Croughan, J., and Ratcliff, K. (1981). The NIMH Diagnostic Interview Schedule: Its history, characteristics, and validity. Arch. Gen. Psychiatry 38: 381–389.
Ross, R. (1999). Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 340: 115–126.
Rozanski, A., Blumenthal, J. A., and Kaplan, J. R. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99: 2192–2217.
Shekelle, R. B., Gale, M., Ostfeld, A. M., and Paul, O. (1983). Hostility, risk of coronary heart disease, and mortality. Psychosom. Med. 45: 109–114.
Smith, T. W. (1992). Hostility and health: Current status of a psychosom.atic hypothesis. Health Psychol. 11: 139–150.
Smith, T. W., and Brown, P. C. (1991). Cynical hostility, attempts to exert social control, and cardiovascular reactivity in married couples. J. Behav. Med. 14: 581–592.
Smith, T. W., Sanders, J. D., and Alexander, J. F. (1990). What does the Cook and Medley hostility scale measure? Affect, behavior, and attributions in the marital context. J. Pers. Soc. Psychol. 58: 699–708.
Spitzer, R. L., Williams, J. B. W., Kroenke, K., Linzer, M., deGruy, F. V., Hahn, S. R., Brody, D., and Johnson, J. G. (1994). Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA 272: 1749–1756.
Steer, R. A., and Beck, A. T. (1996). Beck Depression Inventory. In Sederer, L. I., and Dickey, B. (Eds.), Outcomes Assessment in Clinical Practice, Williams and Wilkins, London, pp. 100–104.
Suarez, E. C. (1999). Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women. Psychosom. Med. 61: 273–279.
Suarez, E. C. (in press). The joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration in apparently healthy men. Psychosom. Med.
Suarez, E. C., Bates, M. P., and Harralson, T. L. (1998). The relation of hostility to lipids and lipoproteins in women: Evidence for the role of antagonistic hostility. Ann. Behav. Med. 20: 59–63.
Yirmira, R. (1996). Endotoxin produces a depressive-like episode in rats. Brain Res. 711: 163–174.